Yifeng Pharmacy Chain Co., Ltd. (SHA:603939)

Yifeng Pharmacy Chain Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,119	3,579	3,566	4,113	2,921	3,360
Short-Term Investments	-	-	-	-	-	4
Trading Asset Securities	4,995	4,407	1,631	50.05	152.19	744.84
Cash & Short-Term Investments	8,114	7,986	5,197	4,163	3,073	4,109
Cash Growth	0.70%	53.67%	24.84%	35.46%	-25.22%	146.78%
Accounts Receivable	1,506	2,153	2,150	1,846	1,087	831.17
Other Receivables	428.71	477.94	448.54	419.47	323.6	207.6
Receivables	1,934	2,631	2,599	2,265	1,411	1,039
Inventory	4,385	4,528	3,808	3,615	3,041	2,172
Prepaid Expenses	-	-	-	-	35.17	-
Other Current Assets	657.1	710.58	525.62	535.91	356.71	341.71
Total Current Assets	15,090	15,856	12,129	10,578	7,916	7,662
Property, Plant & Equipment	5,046	5,679	5,665	4,892	4,504	3,550
Long-Term Investments	132.8	530.22	592.97	334.09	6.72	6.72
Goodwill	4,772	4,769	4,611	4,188	3,718	3,338
Other Intangible Assets	458.69	483.09	470.97	478.2	389.25	370.68
Long-Term Deferred Tax Assets	130.15	148.62	138.67	127.68	109.79	74.15
Long-Term Deferred Charges	434.48	493.88	499.14	430.69	379.59	267.45
Other Long-Term Assets	7.76	15.17	30.27	7.23	28.39	58.37
Total Assets	26,071	27,975	24,137	21,036	17,052	15,327
Accounts Payable	7,942	9,492	8,171	6,761	4,806	3,822
Accrued Expenses	374.41	587.26	549.68	683.11	390	332.21
Short-Term Debt	20.02	30.03	-	-	-	380.32
Current Portion of Long-Term Debt	1,174	66	103.48	92.92	4.21	58.9
Current Portion of Leases	-	1,271	1,355	1,185	931.44	748.43
Current Income Taxes Payable	313.89	207.1	165.76	176.87	148.83	78.14
Current Unearned Revenue	159.03	130.07	80.17	60.69	41.1	30.54
Other Current Liabilities	628.81	814.24	844.45	700.13	424.11	416.39
Total Current Liabilities	10,613	12,598	11,269	9,659	6,745	5,867
Long-Term Debt	1,639	1,601	133.62	228.67	365.65	1,976
Long-Term Leases	1,872	2,313	2,206	1,951	2,024	1,766
Long-Term Unearned Revenue	53.3	53.63	54.09	54.69	50.34	51.46
Long-Term Deferred Tax Liabilities	12.37	15.41	26.76	23.71	2.16	2.41
Total Liabilities	14,189	16,581	13,689	11,917	9,187	9,664
Common Stock	1,212	1,212	1,011	721.7	718.77	531.52
Additional Paid-In Capital	3,651	3,545	3,716	3,991	3,988	2,594
Retained Earnings	6,096	5,693	4,973	3,849	2,802	2,080
Treasury Stock	-3.51	-3.76	-42.24	-77.41	-27.76	-63.02
Comprehensive Income & Other	221.56	278.95	147.93	68.34	-	215.67
Total Common Equity	11,178	10,726	9,804	8,553	7,481	5,359
Minority Interest	704.81	667.88	642.66	565.39	383.24	304.81
Shareholders' Equity	11,882	11,394	10,447	9,119	7,865	5,663
Total Liabilities & Equity	26,071	27,975	24,137	21,036	17,052	15,327
Total Debt	4,705	5,281	3,798	3,458	3,325	4,930
Net Cash (Debt)	3,409	2,705	1,399	705.02	-252.57	-821.45
Net Cash Growth	35.98%	93.32%	98.44%	-	-	-
Net Cash Per Share	2.72	2.19	1.16	0.58	-0.21	-0.71
Filing Date Shares Outstanding	1,212	1,212	1,213	1,212	1,208	1,208
Total Common Shares Outstanding	1,212	1,212	1,213	1,212	1,208	1,161
Working Capital	4,477	3,258	859.44	918.95	1,171	1,795
Book Value Per Share	9.22	8.85	8.08	7.05	6.20	4.62
Tangible Book Value	5,947	5,474	4,723	3,887	3,374	1,650
Tangible Book Value Per Share	4.91	4.51	3.89	3.21	2.79	1.42
Buildings	-	1,364	1,291	1,004	683.76	415.71
Machinery	-	1,174	1,001	843.34	722.34	546.17
Construction In Progress	-	228.58	175.12	239.85	358.64	235.87

Source: S&P Global Market Intelligence. Standard template. Financial Sources.